<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Nevada National Board Professional Learning Institute | Edvardsen | Activity</title>
	<link>http://www.nationalboardinstitute.com/members/maracadress3/activity/</link>
	<atom:link href="http://www.nationalboardinstitute.com/members/maracadress3/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Edvardsen.</description>
	<lastBuildDate>Fri, 23 May 2025 17:06:54 -0700</lastBuildDate>
	<generator>https://buddypress.org/?v=9.1.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">ceac8ba1aac3040392010702bf0da3ba</guid>
				<title>Edvardsen posted an update: Our novel protocol of tissue culture may be applicable for [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/41912/</link>
				<pubDate>Sat, 08 Feb 2025 11:31:31 -0800</pubDate>

									<content:encoded><![CDATA[<p>Our novel protocol of tissue culture may be applicable for eye banks to optimize corneal grafting. © 2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley &amp; Sons Ltd.Small open reading frames (sORFs) which are translate to small peptides (100 amino acids or fewer in&hellip;<span class="activity-read-more" id="activity-read-more-41912"><a href="http://www.nationalboardinstitute.com/activity/p/41912/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">0e3aa55d3b00c7048ad9b878a7ca1e54</guid>
				<title>Edvardsen posted an update: Electrokinetic remediation (EKR) is one of the most [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/40420/</link>
				<pubDate>Thu, 06 Feb 2025 16:18:56 -0800</pubDate>

									<content:encoded><![CDATA[<p>Electrokinetic remediation (EKR) is one of the most successful remediation techniques to treat the sediments contaminated with heavy metals. EDTA is the most widely used enhancing agent to improve the transport process in EKR. But often the generated effluents from EKR contains a high concentration of heavy metals, which cannot be disposed of&hellip;<span class="activity-read-more" id="activity-read-more-40420"><a href="http://www.nationalboardinstitute.com/activity/p/40420/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">b41a42c3e0f22c1265e3886a754b6335</guid>
				<title>Edvardsen posted an update: PVE with aHSC application is a safe and useful method for [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/38571/</link>
				<pubDate>Tue, 04 Feb 2025 11:57:38 -0800</pubDate>

									<content:encoded><![CDATA[<p>PVE with aHSC application is a safe and useful method for FLRV growth. It significantly increases secondary CLMs resectability. However, it can cause CLMs progression. Liver resection should, therefore, be performed as soon as possible after achieving optimal increase of FLRV.</p>
<p>PVE with aHSC application is a safe and useful method for FLRV&hellip;<span class="activity-read-more" id="activity-read-more-38571"><a href="http://www.nationalboardinstitute.com/activity/p/38571/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">c19345f73d52063be49eb80bc51d6653</guid>
				<title>Edvardsen posted an update: 05). Barium swallow was available in 37 patients (84.1%) at [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/37782/</link>
				<pubDate>Mon, 03 Feb 2025 12:12:50 -0800</pubDate>

									<content:encoded><![CDATA[<p>05). Barium swallow was available in 37 patients (84.1%) at 1year after surgery. Radiologic recurrence was observed in two patients (4.5%). No patient had symptoms attributable to recurrence or required revisional surgery. There were no mesh-related complications at 3years follow-up.</p>
<p> The use of biosynthetic mesh for crural reinforcement is&hellip;<span class="activity-read-more" id="activity-read-more-37782"><a href="http://www.nationalboardinstitute.com/activity/p/37782/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">a5779b26fe1184178b304d146d0c7261</guid>
				<title>Edvardsen posted an update: 1 (95% CI, 9.7-14.5) months respectively. Immune checkpoint [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/30692/</link>
				<pubDate>Tue, 28 Jan 2025 15:36:11 -0800</pubDate>

									<content:encoded><![CDATA[<p>1 (95% CI, 9.7-14.5) months respectively. Immune checkpoint inhibitors (ICIs) were given in 115 patients (26.1%) prior to regorafenib. There were no differences in PFS and OS with regorafenib according to the prior use of ICIs (PFS, P = .61; OS, P = .63). The occurrence of hand-foot skin reaction (HFSR) was associated with a better OS (P less then&hellip;<span class="activity-read-more" id="activity-read-more-30692"><a href="http://www.nationalboardinstitute.com/activity/p/30692/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">b3e63cb49c80d8c7340489d36cc16e56</guid>
				<title>Edvardsen became a registered member</title>
				<link>http://www.nationalboardinstitute.com/activity/p/30649/</link>
				<pubDate>Tue, 28 Jan 2025 15:32:38 -0800</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>